Associated Engifab Company Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 03-12-2024
- Paid Up Capital ₹ 1.25 Cr
as on 03-12-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.01 Cr
as on 03-12-2024
- Revenue 12.18%
(FY 2022)
- Profit 12.39%
(FY 2022)
- Ebitda -28.77%
(FY 2022)
- Net Worth 4.47%
(FY 2022)
- Total Assets 10.74%
(FY 2022)
About Associated Engifab Company
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹5.01 Cr.
Rajiv Chopra and Mitali Chopra serve as directors at the Company.
- CIN/LLPIN
U27100JH2003PTC010400
- Company No.
010400
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Singhbhum, Jharkhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Associated Engifab Company?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Chopra  | Director | 03-Nov-2003 | Current |
| Mitali Chopra | Director | 15-Apr-2009 | Current |
Financial Performance of Associated Engifab Company.
Associated Engifab Company Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.18% increase. The company also saw a substantial improvement in profitability, with a 12.39% increase in profit. The company's net worth moved up by a moderate rise of 4.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Associated Engifab Company?
In 2020, Associated Engifab Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Dec 2021 | ₹9.10 M | Open |
Others Creation Date: 27 May 2020 | ₹3.00 M | Open |
Bank Of Baroda Creation Date: 23 Aug 2004 | ₹3.80 Cr | Open |
How Many Employees Work at Associated Engifab Company?
Associated Engifab Company has a workforce of 12 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Associated Engifab Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Associated Engifab Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
